Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 8/20 | 0.35 |
| ▸ | CA2 | P00918 | 8/20 | 0.35 |
| ▸ | CA12 | O43570 | 5/20 | 0.35 |
| ▸ | CA7 | P43166 | 5/20 | 0.35 |
| ▸ | CA13 | Q8N1Q1 | 5/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5950044 | 0.79 | CA2 (0.34) | CA1CA2CA12CA7CA9 | |
| SCHEMBL6336252 | 0.74 | KMT2A (0.44) | — | |
| SCHEMBL1771806 | 0.70 | CA2 (0.40) | CA1CA2 | |
| SCHEMBL3790743 | 0.67 | CA1 (0.49) | CA1CA2CA12CA7CA13 | |
| SCHEMBL3136643 | 0.65 | HSD11B1 (0.43) | CA1CA2CA12CA7CA13 | |
| SCHEMBL2898480 | 0.65 | HSD11B1 (0.43) | CA1CA2CA12CA7CA13 | |
| SCHEMBL384539 | 0.65 | CA1 (0.46) | CA1CA2CA12CA7CA13 | |
| SCHEMBL4127175 | 0.64 | CA1 (0.39) | CA1CA2CA12CA7CA13 | |
| SCHEMBL503664 | 0.63 | CA1 (0.38) | CA1CA2CA12CA7CA13 | |
| SCHEMBL3335900 | 0.63 | CA2 (0.66) | CA1CA2CA12CA7CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10191371-B2 | Underlayer composition and method of imaging underlayer | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2019-01-29 | — | — | US | disclosed |
| US-10078263-B2 | Underlayer composition and method of imaging underlayer composition | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-09-18 | — | — | US | disclosed |
| US-20140335454-A1 | UNDERLAYER COMPOSITION AND METHOD OF IMAGING UNDERLAYER | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2014-11-13 | — | — | US | disclosed |
| US-20140335455-A1 | UNDERLAYER COMPOSITION AND METHOD OF IMAGING UNDERLAYER COMPOSITION | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2014-11-13 | — | — | US | disclosed |
| US-8822124-B2 | Underlayer composition and method of imaging underlayer composition | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-09-02 | — | — | US | disclosed |
| US-8822133-B2 | Underlayer composition and method of imaging underlayer | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2014-09-02 | — | — | US | disclosed |
| US-20120088192-A1 | UNDERLAYER COMPOSITION AND METHOD OF IMAGING UNDERLAYER | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-12 | — | — | US | disclosed |
| US-20120088188-A1 | UNDERLAYER COMPOSITION AND METHOD OF IMAGING UNDERLAYER COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-12 | — | — | US | disclosed |
| US-7335787-B2 | Method for producing onium salt derivatives, and novel onium salt derivatives | TOYO GOSEI KOGYO CO., LTD. (JP) | 2008-02-26 | — | — | US | disclosed |
| US-20050176982-A1 | Method for producing onium salt derivatives, and novel onium salt derivatives | TOYO GOSEI KOGYO CO., LTD. (JP) | 2005-08-11 | — | — | US | disclosed |
| US-6620957-B1 | Process for producing onium salt derivative and novel onium salt derivative | TOYO GOSEI KOGYO CO., LTD. (JP) | 2003-09-16 | — | — | US | disclosed |
| EP-1164127-A1 | PROCESS FOR PRODUCING ONIUM SALT DERIVATIVE AND NOVEL ONIUM SALT DERIVATIVE | Toyo Gosei Kogyo Co., Ltd. (JP) | 2001-12-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176982-A1 | Method for producing onium salt derivatives, and novel onium salt derivatives | STS, NANS, GRIK5 | CA1 118/4885CA2 6/4885CA12 709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.